Researchers are warning patients with a high hemoglobin glycation index are at increased risk for chronic kidney disease.

The hemoglobin glycation index (HGI) is a biomarker used in assisting a prediction of whether the patient will develop pre-diabetes or type 2 diabetes. It can also be used in the prediction of potential kidney injury in patients who have impaired glucose metabolism.

In one study, 2,187 adults with prediabetes or type 2 diabetes were looked at, using data from the Korean Genome and Epidemiologic Study. HGI was figured out, by measuring HbA1c minus predicted HbA1c. Then, researchers calculated from the linear relationship between HbA1c and fasting plasma glucose levels.

Estimated glomerular filtration rate of less than 60 mL/min/1.73 m2 and decreased by more than 25% from baseline during follow-up determine incident CKD.

Researchers found the overall prevalence of chronic was 335 (15.3%) during the follow-up examinations 10 years later. Patients with the highest chronic kidney disease prevalence were 21.5% of the adults. For more of the latest kidney studies, you need to be watching our YouTube, always updated daily with content that’s fresh and free.